These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 15748544)
41. [Management of acne in adolescents]. Faure M Arch Pediatr; 2007 Sep; 14(9):1152-6. PubMed ID: 17624743 [TBL] [Abstract][Full Text] [Related]
42. The pathophysiology of acne vulgaris in children and adolescents, part 2: Tailoring treatment. Bergfeld WF Cutis; 2004 Sep; 74(3):189-92. PubMed ID: 15499761 [TBL] [Abstract][Full Text] [Related]
43. Comparative efficacy and safety results of two topical combination acne regimens. Kircik LH J Drugs Dermatol; 2009 Jul; 8(7):624-30. PubMed ID: 19588638 [TBL] [Abstract][Full Text] [Related]
44. Novel topical drug delivery systems and their potential use in acne vulgaris. Taglietti M; Hawkins CN; Rao J Skin Therapy Lett; 2008 Jun; 13(5):6-8. PubMed ID: 18648713 [TBL] [Abstract][Full Text] [Related]
45. Topical taurine bromamine, a new candidate in the treatment of moderate inflammatory acne vulgaris: a pilot study. Marcinkiewicz J; Wojas-Pelc A; Walczewska M; Lipko-Godlewska S; Jachowicz R; Maciejewska A; Białecka A; Kasprowicz A Eur J Dermatol; 2008; 18(4):433-9. PubMed ID: 18573718 [TBL] [Abstract][Full Text] [Related]
46. Increased interferon-gamma, interleukin-12p40 and IL-8 production in Propionibacterium acnes-treated peripheral blood mononuclear cells from patient with acne vulgaris: host response but not bacterial species is the determinant factor of the disease. Sugisaki H; Yamanaka K; Kakeda M; Kitagawa H; Tanaka K; Watanabe K; Gabazza EC; Kurokawa I; Mizutani H J Dermatol Sci; 2009 Jul; 55(1):47-52. PubMed ID: 19375895 [TBL] [Abstract][Full Text] [Related]
47. Resolution of inflammatory acne vulgaris may involve regulation of CD4+ T-cell responses to Propionibacterium acnes. Wilcox HE; Farrar MD; Cunliffe WJ; Holland KT; Ingham E Br J Dermatol; 2007 Mar; 156(3):460-5. PubMed ID: 17300234 [TBL] [Abstract][Full Text] [Related]
56. [Treatment of mild to moderate acne]. Chivot M Ann Dermatol Venereol; 2003 Jan; 130(1 Pt 2):132-5. PubMed ID: 12605143 [No Abstract] [Full Text] [Related]
57. [Cytotoxicity in acne vulgaris]. Vignale RA; Espasandín J; Lasalvia E; Borras A Med Cutan Ibero Lat Am; 1982; 10(1):31-6. PubMed ID: 6214674 [TBL] [Abstract][Full Text] [Related]
58. Are retinoid/antibiotic fixed-dose combination acne treatments associated with antibiotic resistance? Dréno B; Lambert J; Bettoli V Eur J Dermatol; 2016; 26(1):90-1. PubMed ID: 27023018 [No Abstract] [Full Text] [Related]
59. Effect of zinc gluconate on propionibacterium acnes resistance to erythromycin in patients with inflammatory acne: in vitro and in vivo study. Dreno B; Foulc P; Reynaud A; Moyse D; Habert H; Richet H Eur J Dermatol; 2005; 15(3):152-5. PubMed ID: 15908296 [TBL] [Abstract][Full Text] [Related]
60. A current review of topical benzoyl peroxide: new perspectives on formulation and utilization. Tanghetti EA; Popp KF Dermatol Clin; 2009 Jan; 27(1):17-24. PubMed ID: 18984364 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]